TSE:6869Medical Equipment
Sysmex (TSE:6869) Could Be 30% Undervalued Following Raised Earnings Guidance
Sysmex (TSE:6869) lifted its earnings guidance for the six months to September 2026 and the full year to March 2027, citing stronger hematology instrument sales in the Americas and favorable yen depreciation.
See our latest analysis for Sysmex.
The improved guidance appears to have fed into sentiment around Sysmex, with the stock showing strong short term momentum. The 7 day share price return of 16.17% and 90 day share price return of 38.87% contrast with a 5 year total shareholder return...